Therapeutic Potential of a Self-Assembling Peptide Hydrogel to Treat Colonic Injuries Associated with Inflammatory Bowel Disease.
colitis
self-assembling peptide hydrogel
ulcer
Journal
Journal of Crohn's & colitis
ISSN: 1876-4479
Titre abrégé: J Crohns Colitis
Pays: England
ID NLM: 101318676
Informations de publication
Date de publication:
25 Sep 2021
25 Sep 2021
Historique:
pubmed:
18
2
2021
medline:
2
2
2022
entrez:
17
2
2021
Statut:
ppublish
Résumé
The Self-assembling Peptide Hydrogel [SAPH, PuraMatrix], a fully synthetic peptide solution designed to replace collagen, has recently been used to promote mucosal regeneration in iatrogenic ulcers following endoscopic submucosal dissection. Herein, we evaluated its utility in ulcer repair using a rat model of topical trinitrobenzene sulphonic acid [TNBS]-induced colonic injuries. Colonic injuries were generated in 7-week-old rats by injecting an ethanol solution [35%, 0.2 mL] containing 0.15 M TNBS into the colonic lumen. At 2 and 4 days post-injury, the rats were subjected to endoscopy, and SAPH [or vehicle] was topically applied to the ulcerative lesion. Time-of-flight secondary ion mass spectrometry [TOF-SIMS] was used to detect SAPH. Colonic expression of cytokines and wound healing-related factors were assessed using real-time polymerase chain reaction or immunohistochemistry. SAPH treatment significantly reduced ulcer length [p = 0.0014] and area [p = 0.045], while decreasing colonic weight [p = 0.0375] and histological score [p = 0.0005] 7 days after injury. SAPH treatment also decreased colonic expression of interleukin [IL]-1α [p = 0.0233] and IL-6[p = 0.0343] and increased that of claudin-1 [p = 0.0486] and villin [p = 0.0183], and β-catenin staining [p = 0.0237]. TOF-SIMS revealed lesional retention of SAPH on day 7 post-injury. Furthermore, SAPH significantly promoted healing in in vivo mechanical intestinal wound models. SAPH application effectively suppressed colonic injury, downregulated inflammatory cytokine expression, and upregulated wound healing-related factor expression in the rat model; thus, it may represent a promising therapeutic strategy for IBD-related colonic ulcers.
Sections du résumé
BACKGROUND AND AIMS
OBJECTIVE
The Self-assembling Peptide Hydrogel [SAPH, PuraMatrix], a fully synthetic peptide solution designed to replace collagen, has recently been used to promote mucosal regeneration in iatrogenic ulcers following endoscopic submucosal dissection. Herein, we evaluated its utility in ulcer repair using a rat model of topical trinitrobenzene sulphonic acid [TNBS]-induced colonic injuries.
METHODS
METHODS
Colonic injuries were generated in 7-week-old rats by injecting an ethanol solution [35%, 0.2 mL] containing 0.15 M TNBS into the colonic lumen. At 2 and 4 days post-injury, the rats were subjected to endoscopy, and SAPH [or vehicle] was topically applied to the ulcerative lesion. Time-of-flight secondary ion mass spectrometry [TOF-SIMS] was used to detect SAPH. Colonic expression of cytokines and wound healing-related factors were assessed using real-time polymerase chain reaction or immunohistochemistry.
RESULTS
RESULTS
SAPH treatment significantly reduced ulcer length [p = 0.0014] and area [p = 0.045], while decreasing colonic weight [p = 0.0375] and histological score [p = 0.0005] 7 days after injury. SAPH treatment also decreased colonic expression of interleukin [IL]-1α [p = 0.0233] and IL-6[p = 0.0343] and increased that of claudin-1 [p = 0.0486] and villin [p = 0.0183], and β-catenin staining [p = 0.0237]. TOF-SIMS revealed lesional retention of SAPH on day 7 post-injury. Furthermore, SAPH significantly promoted healing in in vivo mechanical intestinal wound models.
CONCLUSIONS
CONCLUSIONS
SAPH application effectively suppressed colonic injury, downregulated inflammatory cytokine expression, and upregulated wound healing-related factor expression in the rat model; thus, it may represent a promising therapeutic strategy for IBD-related colonic ulcers.
Identifiants
pubmed: 33596312
pii: 6141509
doi: 10.1093/ecco-jcc/jjab033
pmc: PMC8464220
doi:
Substances chimiques
Cytokines
0
Hydrogels
0
Peptides
0
RADA16-I
0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
1517-1527Subventions
Organisme : Ministry of Science and Education and Health and Labour Sciences Research
Organisme : Ministry of Health
Organisme : Labour and Welfare of Japan
Informations de copyright
© The Author(s) 2021. Published by Oxford University Press on behalf of European Crohn’s and Colitis Organisation.
Références
Gastrointest Endosc. 2016 Jun;83(6):1259-64
pubmed: 26608126
J Exp Med. 2009 Jul 6;206(7):1465-72
pubmed: 19564350
Curr Gastroenterol Rep. 2007 Oct;9(5):422-8
pubmed: 17991345
Annu Rev Physiol. 2019 Feb 10;81:189-209
pubmed: 30354933
Curr Drug Targets. 2015;16(3):209-18
pubmed: 25585127
Lancet. 2012 Nov 3;380(9853):1606-19
pubmed: 22914296
World J Gastroenterol. 2019 Jan 28;25(4):418-432
pubmed: 30700939
Gastroenterol Clin North Am. 2009 Jun;38(2):333-52
pubmed: 19446262
Gastroenterology. 1989 Mar;96(3):795-803
pubmed: 2914642
Trends Pharmacol Sci. 2017 Feb;38(2):127-142
pubmed: 27916280
Dtsch Arztebl Int. 2016 Feb 5;113(5):72-82
pubmed: 26900160
Biopolymers. 1994 May;34(5):663-72
pubmed: 8003624
Mucosal Immunol. 2014 Jan;7(1):6-19
pubmed: 24084775
J Clin Invest. 2007 Mar;117(3):514-21
pubmed: 17332878
Science. 2012 Oct 5;338(6103):108-13
pubmed: 22956684
Gastrointest Endosc. 2020 May;91(5):1172-1182
pubmed: 31904381
Nat Rev Immunol. 2014 May;14(5):329-42
pubmed: 24751956
Am J Gastroenterol. 2000 May;95(5):1239-43
pubmed: 10811334
Gastroenterology. 2010 Dec;139(6):1837-1843.e1
pubmed: 20955705
PLoS One. 2014 May 06;9(5):e96801
pubmed: 24802416
Dig Dis Sci. 2018 Sep;63(9):2180-2188
pubmed: 29948565
Immunity. 2006 Aug;25(2):189-91
pubmed: 16920636
Curr Gastroenterol Rep. 2007 Oct;9(5):429-33
pubmed: 17991346
Int J Nanomedicine. 2013;8:2629-40
pubmed: 23926427
Proc Natl Acad Sci U S A. 2009 Jan 6;106(1):256-61
pubmed: 19109436
J Pharmacol Sci. 2005 Dec;99(4):329-34
pubmed: 16314691
Lancet. 2017 Apr 29;389(10080):1741-1755
pubmed: 27914655
Brain Res. 2019 May 15;1711:226-235
pubmed: 30703369
Curr Opin Pharmacol. 2015 Dec;25:56-61
pubmed: 26645664
Lancet Gastroenterol Hepatol. 2018 Sep;3(9):644-653
pubmed: 30102183
Gastroenterology. 1994 Dec;107(6):1643-52
pubmed: 7958674
Inflamm Bowel Dis. 2020 Apr 11;26(5):709-719
pubmed: 31821463
J Pharmacol Exp Ther. 2008 Aug;326(2):523-31
pubmed: 18448866
J Am Soc Mass Spectrom. 2005 Oct;16(10):1608-18
pubmed: 16112869
World J Gastroenterol. 2016 Mar 21;22(11):3117-26
pubmed: 27003989
Anal Bioanal Chem. 2013 May;405(12):4039-49
pubmed: 23430186
Inflamm Bowel Dis. 2008 Oct;14 Suppl 2:S119-20
pubmed: 18816710
Clin Exp Gastroenterol. 2015 Aug 17;8:257-69
pubmed: 26316792
Lancet Gastroenterol Hepatol. 2017 Jul;2(7):521-530
pubmed: 28606878